3SBio (SSRX) Submits Application to China SFDA for Feraheme Iron Therapy
Tweet Send to a Friend
3SBio Inc. (NASDAQ: SSRX) today announced that it has submitted its application for a registrational clinical trial to the Chinese ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
